HSV-1 targets specific genomic regions to enhance viral replication. An experimental cancer drug shows promise in blocking HSV-1 replication by targeting stolen transcription proteins. Could work against other viruses.
A man diagnosed with Oropouche fever this summer still had functional virus in his semen 16 days after his symptoms started, a different group of researchers report in the December Emerging Infectious Diseases.
Genetic sequencing of cases in Rwanda has revealed that the virus jumped from an animal, like an Egyptian fruit bat or an African green monkey, to a person just once in the ongoing outbreak, the country’s health minister tweeted on 20 October.
